Get In Touch
Eleftha 150mg Injection, containing Trastuzumab as its active component, is primarily used to treat HER2-positive breast cancer. In patients with HER2-positive breast cancer, the cancer cells are predominantly composed of HER2 proteins, which accelerate tumor growth. This medication is also indicated for treating metastatic gastric cancer with elevated HER2 protein levels.
Trastuzumab Injection
INTAS PHARMACEUTICALS LTD
Breast Cancer
Vial
Injection
HER2-positive breast cancer is particularly aggressive. Targeted therapy for HER2-positive breast cancer, like Eleftha 150mg Injection, works by specifically targeting the proteins responsible for cancer growth, development, and spread. It is crucial to use effective birth control during the treatment and for at least 7 months after the final dose.
Eleftha 150mg Injection is not recommended for patients under 18 years old, those with severe breathing problems, or those requiring oxygen treatment. Inform your physician if you have any heart issues, breathlessness, or have undergone other cancer treatments. Additionally, disclose all medications, including supplements and herbal medicines, before starting treatment with Canmab Injection.
The Eleftha 150mg and Eleftha 150mg variants are available for different dosage requirements. When considering Eleftha 150mg or Eleftha 150mg Injections, it’s essential to consult with your healthcare provider about the appropriate dosage and administration.
For those looking into the cost, the Eleftha 150mg price and the Eleftha 150mg price vary. The vivitra 150mg injectionprice in India can fluctuate based on the supplier and location. Always check with local pharmacies or medical providers for the most accurate pricing information.
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.
1. Store vivitra 150mg injectionInjection in a refrigerator at temperatures between 2–8°C.
2. Protect from light and keep out of children's reach.
3. Eleftha 150mg Injection should not be used during pregnancy as it may harm the fetus; consult your doctor if you are pregnant.
4. Avoid using Eleftha 150mg Injection while breastfeeding and for seven months after the final dose.
Abirapro may cause side effects and/or use impacts if administered with other medicines, vitamins, and herbal supplements. Before starting Abirapro, your doctor should be completely aware of your medical history, previous ongoing treatments and prescriptions. Specific precautions that need to be taken:
Yes. It is recommended that complete medical history be disclosed to your physician before starting treatment with Abirapro. An alternate medication is likewise recommended. Further, you need to necessarily disclose to your physician if you have:
The most common side effects are:
Persistence in any of the symptoms may lead to fatal side effects. Refer your doctor immediately if you suffer any such symptoms for alternate medicine or additional medication to curb them.
Abirapro is not a cancer treatment drug. It is a hormonal treatment to slow growth of prostate cancer in men.
Specific studies to prove its efficiency/cure in any other type of cancer is yet not available.
No. Self-medication is strictly prohibited. Abirapro is known to have serious side effects. Prior consultation by a cancer specialist is strongly recommended. Also patients with pre-existing medical conditions need to disclose their medical history top their doctors before starting treatment with Abirapro.
Consumption of alcohol during administration of Abirapro should be avoided. Though no studies support any reaction of the medicine with alcohol, doctor’s instructions should be sought before consumption.
Yes. Abirapro is advised to be taken empty stomach to curb the side effects of the medicine when taken with food. Adverse effects such as a high blood pressure, muscle weakness, paralysis, and breathing difficulties are common symptoms noticed if medicine is taken along with food. Interval of 1 hour before meal and 2 hours after meal is advised for administration of the medicine.
Yes. Low blood cell count is a symptom. However, it is advisable to bring it to the notice of your physician. Persistent low blood cell count may lead to serious side effects.
Yes. Usage of Abirapro often leads to low blood cell count. To continue taking the medicine during the treatment period, it is advisable to get a regular blood cell count done up.
Administration of Abirapro leads to side effects such as high blood pressure, fluid retention (having too much water in your body), or having reduced levels of potassium in your blood. The risk of the side effects can be fatal. In order to counteract the side-effects of Abirapro, your doctor advises prednisolone.
Swelling of feet and ankles is a serious side-effect to the medicine. Immediate referral of a doctor is advised to curb additional effects. Self-medication to overcome symptoms is strictly prohibited.
Abirapro is a hormonal treatment drug administered to males only undergoing treatment of prostate cancer. No definite study supports the use of Abirapro in pediatric patients or females for any other type of cancer.
Yes. Reduced sex drive (libido) is a common medicinal side effect noticed due to the presence of the compound Abiraterone.
Eleftha 150mg Injection is generally given along with chemotherapy medication such as paclitaxel or docetaxel or platinum compounds. Sometimes, it is also given with hormonal agents for those patients with elevated hormonal status.
Yes, Eleftha 150mg Injection can damage the heart muscles. Hence to prevent the worsening of symptoms, it is advised to do a heart checkup every 3 months and continue till 2–5 years after treatment completion.
No, since it tends to pass into breast milk, it is unsafe to breastfeed. It is advised not to breastfeed for at least 7 months after treatment with Eleftha 150mg Injection.
No, it is unsafe to consume Eleftha 150mg Injection during pregnancy as it can harm the baby by reducing amniotic fluid and cause developmental issues such as poor lung development. If you are planning pregnancy, discuss birth control methods with your doctor as this medicine may affect fertility.
HER2-positive breast cancer is particularly aggressive. Targeted therapy for HER2-positive breast cancer, like Eleftha 150mg Injection, works by specifically targeting the proteins responsible for cancer growth, development, and spread. It is crucial to use effective birth control during the treatment and for at least 7 months after the final dose.
Eleftha 150mg Injection is not recommended for patients under 18 years old, those with severe breathing problems, or those requiring oxygen treatment. Inform your physician if you have any heart issues, breathlessness, or have undergone other cancer treatments. Additionally, disclose all medications, including supplements and herbal medicines, before starting treatment with vivitra 150mg injectionInjection.
The Eleftha 150mg and Eleftha 150mg variants are available for different dosage requirements. When considering Eleftha 150mg or Eleftha 150mg Injections, it’s essential to consult with your healthcare provider about the appropriate dosage and administration.
For those looking into the cost, the Eleftha 150mg price and the Canmab 440 mg price vary. The vivitra 150mg injectionprice in India can fluctuate based on the supplier and location. Always check with local pharmacies or medical providers for the most accurate pricing information.
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.
Eleftha 150mg Injection is generally given along with chemotherapy medication such as paclitaxel or docetaxel or platinum compounds. Sometimes, it is also given with hormonal agents for those patients with elevated hormonal status.
Yes, Eleftha 150mg Injection can damage the heart muscles. Hence to prevent the worsening of symptoms, it is advised to do a heart checkup every 3 months and continue till 2–5 years after treatment completion.
No, since it tends to pass into breast milk, it is unsafe to breastfeed. It is advised not to breastfeed for at least 7 months after treatment with Eleftha 150mg Injection.
No, it is unsafe to consume Eleftha 150mg Injection during pregnancy as it can harm the baby by reducing amniotic fluid and cause developmental issues such as poor lung development. If you are planning pregnancy, discuss birth control methods with your doctor as this medicine may affect fertility.
Sourced from Manufacturers
Air Express Delivery
Trusted Medicines
Get Up to 85% Off
